Status:

UNKNOWN

Operations Research of the 'Real World' Effectiveness of Multi-Month Dispensing of ART for Stable Patients in CARGs in Zimbabwe

Lead Sponsor:

Kheth'Impilo

Collaborating Sponsors:

Ministry of Health and Child Welfare, Zimbabwe

EQUIP Innovation for Health

Conditions:

HIV/AIDS

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This study aims to evaluate the effectiveness of two strategies for multi-month dispensing (MMD) of ART in Community ART Refill Groups (CARGs) on retention, virologic suppression, and cost compared to...

Detailed Description

This study will use a cluster (facility) randomized trial with 3 arms; patients receiving 3 monthly ART supply at facilities-standard of care (3MF) (Control group), patients receiving 3 monthly ART su...

Eligibility Criteria

Inclusion

  • At least 18 years of age and willing and able to provide written informed consent for participation in this study
  • Willing to be part of a CARG if in a facility that has been randomized to 3MC or 6MC,
  • Confirmed HIV-1 infection based on the Zimbabwe National HIV testing algorithm.
  • On ART ≥ 6 months
  • On first line ART regimen
  • No drug toxicity/tolerability issues within the prior 6 months
  • No active opportunistic infection suspected (including TB) and not treated for an opportunistic infection in the last 30 days
  • Viral load \< 1000 copies/ml done at baseline of the study
  • Weight ≥ 35kgs

Exclusion

  • Unwilling or unable to provide informed consent
  • On alternative first line or second line regimen
  • ARV toxicity or tolerability issue within the prior 6 months
  • Co-morbidities requiring facility visits more often than 3 months if in the 3MC/3MF ARMS and 6 monthly if in the 6MC ARM
  • Viral load \> lower limit of standard assay (\>1000) within the prior 6 months
  • Confirmed pregnancy, or less than 18 months postpartum.
  • Weight criteria is less than 35kgs

Key Trial Info

Start Date :

July 28 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 30 2019

Estimated Enrollment :

4676 Patients enrolled

Trial Details

Trial ID

NCT03238846

Start Date

July 28 2017

End Date

September 30 2019

Last Update

October 17 2018

Active Locations (30)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 8 (30 locations)

1

Seke North Clinic

Chitungwiza, Harare, Zimbabwe

2

Seke South Clinic

Chitungwiza, Harare, Zimbabwe

3

St Mary's Clinic

Chitungwiza, Harare, Zimbabwe

4

Zengeza Clinic

Chitungwiza, Harare, Zimbabwe